Skip to main content
Clinical Trials/ACTRN12614000002684
ACTRN12614000002684
Terminated
Phase 2

In children less than 5 years old with nappy rash will topical medical grade Kanuka honey reduce nappy rash severity compared with Bepanthen Nappy Rash Ointment, and is it acceptable to parents/caregivers.

Honeylab Ltd0 sites138 target enrollmentJanuary 2, 2014

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
appy Rash
Sponsor
Honeylab Ltd
Enrollment
138
Status
Terminated
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 2, 2014
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Honeylab Ltd

Eligibility Criteria

Inclusion Criteria

  • Aged less than 5 years old at the time of enrolment
  • Doctor’s diagnosis of nappy rash
  • Nappy Rash Severity Score of 2 or greater

Exclusion Criteria

  • Current requirement for systemic corticosteroid, systemic anti\-fungal or systemic antibiotic treatment, or has had systemic corticosteroid, systemic anti\-fungal or systemic antibiotic treatment within 4 weeks prior to Visit 1
  • Current requirement for topical corticosteroid, topical anti\-fungal or topical antibiotic treatment for Nappy Rash
  • Known or suspected allergy to honey or Bepanthen Nappy Rash Ointment
  • Any other condition which, at the investigators discretion, it is believed may present a safety risk or impact on the feasibility of the study or the study results

Outcomes

Primary Outcomes

Not specified

Similar Trials